Cargando…
P1364: PHARMACOKINETIC PROFILE OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A), FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T CELL THERAPY FOR PATIENTS WITH RELAPSED/ REFRACTORY B CELL MALIGNANCIES (IMAGINE STUDY)
Autores principales: | Malhotra, Pankaj, Bhat, Sunil, Damodar, Sharat, Thirumalairaj, Raja, Raj, Revathy, Mallya, Pooja, Nayak, Akshatha, Joshi, Ravi, Chougule, Sudarshan, Mb, Deepak, Dhar, Sudeshna, Roshan Joseph, Anne, Kumar Mg, Arun, Kumar, Jeetendra, Soares, Melina, Yadav, Sunil, Arasu, Pallavi, Ramulu Elluru, Sri, Manzoor Akheel, Mohammed, Nahar, Rahul, Kamat, Anil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430551/ http://dx.doi.org/10.1097/01.HS9.0000972344.27987.52 |
Ejemplares similares
-
P1409: PHASE-2 STUDY OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FIRST-IN-INDIA INDUSTRY CD19-DIRECTED CAR-T WITH FRACTIONATED INFUSIONS FOR PATIENTS WITH RELAPSED REFRACTORY B CELL MALIGNANCIES: IMAGINE STUDY
por: Malhotra, Pankaj, et al.
Publicado: (2023) -
P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED/ REFRACTORY CD19+ NON-HODGKIN LYMPHOMA
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2023) -
Safety and efficacy of letetresgene autoleucel alone or with pembrolizumab for relapsed/refractory multiple myeloma
por: Nishihori, Taiga, et al.
Publicado: (2022) -
The -1364A/C Aquaporin 5 Gene Promoter Polymorphism Is Not Associated with Menière's Disease
por: Arweiler-Harbeck, Diana, et al.
Publicado: (2012) -
AQP5-1364A/C Polymorphism Affects AQP5 Promoter Methylation
por: Rump, Katharina, et al.
Publicado: (2022)